Summary: On February 8, 2022, the National Institute of Industrial Property (INPI) published a notice in Gazette 2666 detailing new rules for…
Biopharmaceutical
-
-
Patent LitigationPatents
Seagen Scores $41.8M in Enhertu Patent Case Against Daiichi Sankyo
by adminby adminSummary : A federal jury has awarded biotechnology company Seagen Inc. $41.8 million in a patent infringement lawsuit against Daiichi Sankyo Co.…
-
CompaniesIntellectual Property (IP)Patent LitigationPatentsSandoz
Sandoz and Teva Invalidate Patent and SPC of Blockbuster Apixaban
by adminby adminSummary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the…
-
Mankind Pharma
Mankind Pharma Makes a Move into the Agri-Tech Sector Plans to Invest Rs 200 Crore.
by adminby adminSynopsis : Mankind Pharma is planning to invest up to Rs 200 crore in the first two to three years in the…
-
CompaniesMerger / AcquisitionNovartis
Sandoz Acquires Drug Delivery Device Firm Coalesce
by adminby adminSummary : Sandoz acquired the capabilities and assets of drug delivery device company, Coalesce, to further its existing portfolio of respiratory medicines…
-
Europe Medicine Agency (EMA)Regulatory
EMA establishes a Cancer Medicines Forum to optimize Cancer Treatments in Clinical practice
by adminby adminSummary EMA has launched the Cancer Medicines Forum (CMF) in collaboration with the European Organization for Research and Treatment of Cancer (EORTC).…
-
Covid DrugsPharma Science & Research
Alpaca nanobodies potently neutralize SARS-CoV-2 variants
by adminby adminSummary : Researchers at Karolinska Institutet in Sweden have developed a novel strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging…
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech receive expanded U.S. emergency use authorization for an additional COVID-19 vaccine booster in individuals aged 50 years and older
by adminby adminSummary: Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded…
-
RegulatoryU.S FDA
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment
by adminby adminSummary : Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug Administration (FDA) has…
-
RegulatoryU.S FDA
CANbridge Pharmaceuticals CAN108 New Drug Application/Orphan Drug Registration (NDA/ORD) for Alagille Syndrome Accepted by the Taiwan Food and Drug Administration
by adminby adminSummary Taiwan Food and Drug Administration (TFDA) has accepted the New Drug Application/Orphan Drug Registration (NDA/ODR) for CAN108 (maralixibat oral solution (LIVMARLI TM))…